secwatch.observer — SEC 8-K summary
======================================

Issuer:     VOLITIONRX LTD (VNRX)
CIK:        0000093314
Form:       8-K
Filed at:   2024-07-03T23:59:59+00:00
Accession:  0001477932-24-004059
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VolitionRx shareholders approve 75% increase in authorized shares to 175M and new equity plan
--------------------------------------------------------------------------------

- Authorized shares increased from 100M to 175M (75% increase), effective July 2, 2024 via Certificate of Amendment.
- 2024 Stock Incentive Plan adopted, reserving 7.5M shares for future equity awards to employees, directors, and consultants.
- Six director nominees elected; auditor Sadler, Gibb & Associates ratified; say-on-pay advisory vote passed.
- All five stockholder proposals at annual meeting passed; 49.0M of 82.8M shares outstanding were voted.
- Both the share increase and equity plan were stockholder-approved and immediately effective.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/93314/000147793224004059/0001477932-24-004059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/93314/000147793224004059/vnrx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-24-004059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer